HARBIN GLORIA PHARMACEUTICALS Co., LTD (SHE:002437)
China flag China · Delayed Price · Currency is CNY
3.280
-0.120 (-3.53%)
Mar 19, 2026, 3:04 PM CST

SHE:002437 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
7,3215,6775,5175,5836,3977,034
Market Cap Growth
28.45%2.89%-1.18%-12.72%-9.06%5.61%
Enterprise Value
6,5845,2775,4305,7946,4817,718
Last Close Price
3.282.492.512.542.913.20
PE Ratio
25.7724.3945.85-142.0117.58
Forward PE
29.8224.5524.5524.5524.5524.55
PS Ratio
3.262.332.101.802.032.30
PB Ratio
3.362.883.233.283.233.64
P/TBV Ratio
4.534.015.015.365.366.48
P/FCF Ratio
19.6816.3122.5624.4226.69-
P/OCF Ratio
17.4913.8120.1221.3423.33551.09
PEG Ratio
-1.371.371.371.371.37
EV/Sales Ratio
2.932.162.071.862.062.53
EV/EBITDA Ratio
-16.0419.7126.8725.451727.71
EV/EBIT Ratio
32.3823.4231.5867.6856.03-
EV/FCF Ratio
17.7015.1622.2025.3527.04-
Debt / Equity Ratio
0.030.000.400.850.790.70
Debt / EBITDA Ratio
-0.012.456.755.99302.75
Debt / FCF Ratio
0.200.012.766.376.50-
Net Debt / Equity Ratio
-0.35-0.26-0.020.100.030.24
Net Debt / EBITDA Ratio
--1.55-0.130.770.25102.30
Net Debt / FCF Ratio
-2.04-1.46-0.150.730.26-14.79
Asset Turnover
0.770.820.730.710.680.56
Inventory Turnover
6.826.005.424.812.302.06
Quick Ratio
1.170.800.670.670.680.53
Current Ratio
1.391.070.820.780.820.70
Return on Equity (ROE)
14.60%13.17%7.54%-15.72%2.75%23.21%
Return on Assets (ROA)
4.34%4.71%2.97%1.22%1.57%-1.66%
Return on Invested Capital (ROIC)
12.62%12.27%7.06%4.38%3.27%-3.92%
Return on Capital Employed (ROCE)
9.20%11.30%9.90%4.90%5.70%-7.30%
Earnings Yield
4.00%4.10%2.18%-5.22%0.70%5.69%
FCF Yield
5.08%6.13%4.43%4.09%3.75%-0.44%
Payout Ratio
0.35%4.02%36.41%-157.49%33.62%
Buyback Yield / Dilution
-4.69%-2.82%-0.05%-0.07%0.04%0.01%
Total Shareholder Return
-4.69%-2.82%-0.05%-0.07%0.04%0.01%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.